- Mosaic emerges from stealth with $47M Seed for robotic endovascular navigation
Mosaic emerges from stealth with $47M Seed for robotic endovascular navigation

- Francis Medical gets J&J backing as it seeks a prostate cancer indication
Francis Medical gets J&J backing as it seeks a prostate cancer indication

- Luminoah raises $25M Series B for its FDA-cleared enteral feeding system
Luminoah raises $25M Series B for its FDA-cleared enteral feeding system

- Claria Medical earns FDA nod for integrated hysterectomy tissue extraction system
Claria Medical has received FDA De Novo authorization for its Claria System, an integrated tissue containment and removal device designed for minimally invasive hysterectomy procedures. The device, which was reviewed under the FDA's Safer Technologies Program (STeP), is the first FDA-authorized syst

- Zeta Surgical receives FDA clearance for robotic TMS stereotactic system
Zeta Surgical has received FDA 510(k) clearance for its TMS Robotic System as a stereotactic instrument, expanding its portfolio of robotic technologies for transcranial magnetic stimulation (TMS). The system is designed to provide real-time robotic positioning of TMS coils with submillimeter accura

- Spiro Robotics earns FDA clearance for image-guided system for tracheal intubation
Spiro Robotics has received FDA 510(k) clearance for Spiro-VISTA, its handheld, dual image-guided robotic system designed to assist with tracheal intubation in adult hospital patients. The Video Intubation System for Total Access (Spiro-VISTA) is indicated for both difficult and routine tracheal int

- Stereotaxis completes $45M Robocath acquisition to strengthen robotic endovascular platform
Stereotaxis has completed its previously announced acquisition of Robocath in a deal valued at up to $45 million, strengthening its position in the endovascular robotics market. The transaction includes an upfront payment of $20 million, with up to $25 million in milestone-based payments tied to reg

- CurifyLabs raises $14M Series A to expand personalized medicine platform
CurifyLabs has raised $14 million in a Series A financing to expand its personalized medicine platform, with proceeds supporting U.S. growth, supply chain expansion, customer support, and product development. The round was co-led by Sandwater and HealthCap, with participation from Tesi and existing

- Jenscare receives CE mark for LuX-Valve Plus tricuspid valve replacement system
Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system, expanding treatment options for patients with severe tricuspid regurgitation. The second-generation device is designed to repla

- Leo Cancer Care raises $65M Series D to scale upright cancer care platform
Leo Cancer Care has raised $65 million in an oversubscribed Series D financing to accelerate the commercialization of its integrated upright cancer care platform across proton therapy, photon therapy, and imaging. The round was led by Yu Galaxy, with participation from new investor Eventide Asset Ma

- Nyra Medical enrolls first patient in mitral valve repair early feasibility study
Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with functional mitral regurgitation (FMR). CARLEN is a single-leaflet implant designed to augment the native mitral valve, res

- AtaCor enrolls first patient in EV-ICD pivotal study with Abbott
AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with Abbott. The investigational system combines AtaCor's Atala parasternal lead with Abbott's E












